N/A N=200 Prevalence of Femoroacetabular Impingement in Asymptomatic Patients
Femoroacetabular Hip Impingement Syndrome
Primary: Prevalence of Femoroacetabular Impingement (FAI) — 28; 172 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=1,108 Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study)
Femoral Neck Fractures
Primary: Revision Surgery — 107; 117 Participants
N/A N=130 Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty
Femoral Neck Fracture
Primary: Mortality — 23.1; 20.1 pecent
N/A N=1,495 Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Adults With Displaced Hip Fractures
Hip Fractures · Femoral Neck Fractures
Primary: Number of Participants With Revision Surgery — 57; 60 Participants
Phase 4 N=6 Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement
Osteoporosis
Primary: Percentage of Participants With Modeling Based Bone Formation in the Femoral Neck — 100 percentage of participants
Phase 4 N=104 Comparison of the Efficiency of Femur Nerve Block and Intravenous Analgesia Treatment in Hip Fracture Patients
Hip Fractures · Analgesia · Femoral Nerve
Primary: Pain Score Change — 4; 2 units on a scale
N/A N=110 Intramedullary Nailing of the Femur:Trochanteric vs Piriformis Starting Portals
Femur Fracture
Primary: Healed Femur Fracture — 31.8; 31.4 Weeks
N/A N=120 Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties
Hip Arthropathy
Primary: Survival Rate of Stems — 94 Percentage of stem unrevised
Phase 3 N=110 Efficacy of Zoledronic Acid in Preventing Collapse of the Osteonecrotic Femoral Head
Avascular Necrosis of Femoral Head
Primary: Number of Participants With Femoral Head Collapse Within 24 Months — 29; 22 participants
Phase 3 N=122 Effect of Teriparatide on Hip Fracture Healing
Femur Neck Fracture
Primary: Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture — 87; 86 percentage of participants
N/A N=150 Biomechanical Reconstruction of Three Different Hip Stem Designs in Hip Dysplasia Using a 3D CT-based Planning Software
Dysplasia; Hip
Primary: Correct Reconstruction CLS — 138 Hips
N/A N=21 THA Kinematics and Sound for Subjects for Normal, Diseased and Implanted Hips
Hip Injuries
Primary: Magnitude of Hip Separation During Primary Heel Strike — -0.591; 0.096; 0.558 mm
N/A N=20 Orthopaedic Treatment Proximal Humeral Fractures
Proximal Humeral Fracture
Primary: Constant Scale Evaluation at 3 Months and 12 Months From the Date of Trauma — 40.1; 51.8 units on a scale — p=<0.01
N/A N=74 LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study
Arthroplasty, Replacement, Hip
Primary: Linear Wear Rate — 0.008 mm/year
N/A N=60 The Viability of Short Stems in Total Hip Arthroplasty
Osteoarthritis of Hip
Primary: Mean VR-12 Mental Composite Score Through 2 Years Post Operative — 47.3; 50.6; 54.9; 53.8 T-Score
N/A N=46 Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders
Chronic Hip Joint Pain · Prearthritic Hip Disease
Primary: Percentage of Participants Who Are Adherent to Treatment Attendance — 21; 22 Participants — p=1.0
Phase 3 N=39 Second Study of the Effect of Teriparatide on Hip Fracture Healing
Femur Neck Fracture
Primary: Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture — 74; 93 Percentage of participants
N/A N=80 Surgical Treatment of Hip Fractures Under Peripheral Regional Anesthesia
Hip Fractures
Primary: Success Rate (Supplemental Medication) — 22; 20; 3 Participants
N/A N=85 Long-term Outcomes of Conical Tapered Stems in Cementless Total Hip Arthroplasty Due to Congenital Hip Pathologies
Dysplasia; Hip · Prosthesis Survival
Primary: Harris Hip Score — 89.8 points
N/A N=62 DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial
Femoral Fracture (Proximal)
Primary: Success in Terms of the Merle D'Aubigne Postel Score for Pain Category — 4.1; 4.4; 4.5; 4.6 Units on a scale
N/A N=188 The CHINA TFNA Study
Femur Fractures
Primary: Successful Fracture Union Rate 24 Weeks After Surgery — 81; 83 Participants
N/A N=15 Functional Movement Retraining After Hip Replacement
Arthroplasty, Replacement, Hip
Primary: Change in Hip Disability and Osteoarthritis Outcomes Score (HOOS) - Activities of Daily Living Scale — -6.00 units on a scale
N/A N=80 A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial
Femoroacetabular Impingement
Primary: Hip Outcome Score - ADL Subscale at 24 Months — 69.3; 73.1 score on a scale
N/A N=80 Knee Bracing for People With Patellofemoral Osteoarthritis
Knee Osteoarthritis
Primary: Change in Pain on the VIsual Analog Scale (VAS) — -.068 change in units on a scale from baseline
N/A N=65 Computer-Assisted Navigation for Intramedullary Nail Fixation of Intertrochanteric Femur Fractures
Intertrochanteric Femur Fractures
Primary: Tip-to-apex Distance — 14.1; 14.9 mm
N/A N=52 Retrospective Study on Radiological Factors Predictive of Psoas Impingement
Hip Impingement Syndrome · Prosthetic Complication
Primary: Acetabular Cup Antiversion — 19.8; 11.5 degree
N/A N=82 Postoperative Hip Bracing After Hip Arthroscopy
Femoroacetabular Impingement Syndrome · Acetabular Labral Tear
Primary: Patient Numerical Pain Ranking Scale (NPRS) — 1.8; 2.3 score on a scale
N/A N=68 Ceramic-on-ceramic THA for Post-traumatic Hip Osteoarthritis After Acetabular Fracture
Hip Osteoarthritis · Post-traumatic Osteoarthritis
Primary: Survival Rates of the Hip Implants — 96.3 percentage of non-revised implants
Phase 4 N=84 Hip Scope Fascia-iliaca (FI) Block Study
Hip Dysplasia · Femoroacetabular Impingement · Acetabular Labrum Tear
Primary: Visual Analog Scale — 2.65; 2.50 units on a scale
Phase 2 N=12 Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
Fibrous Dysplasia Of Bone
Primary: Proportion of Participants With Serum Phosphate Levels Within the Target Range at Week 48 — 1 Proportion of participant